Guardant Health GH Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 64.9%+3.6pp | 64.5%+3.7pp | 63.8%+4.6pp | 62.8%+4.4pp | 61.3%+2.4pp | |
| Operating margin | -41.4%+17.3pp | -44.5%+15.5pp | -49%+25.4pp | -55.6%+23.8pp | -58.8%+29.1pp | |
| Net margin | -40.1%+13.7pp | -42.4%+16.7pp | -44.2%+29.8pp | -49.9%+26.3pp | -53.8%+22.5pp | |
| Returns | ||||||
| Return on invested capital | -132.8%— | -51.8%— | —— | —— | —— | |
| Efficiency | ||||||
| Asset turnover | 0.7×+0.2× | 0.6×+0.1× | 0.6×+0.2× | 0.6×+0.2× | 0.5×+0.1× | |
| Liquidity | ||||||
| Current ratio | 4.7×+0.6× | 4.8×+0.2× | 3.5×-2.7× | 3.7×-2.7× | 4.1×-1.8× | |
| Per Share | ||||||
| Book value per share | -$1.38+31.9% | -$0.79+30.4% | -$2.84-482% | -$2.46-18,545% | -$2.02-461% | |
| Valuation | ||||||
| Market capitalization | $12.12B+130% | $13.27B+251% | $7.79B+176% | $6.19B+75.2% | $5.26B+109% | |
| Price / sales | 11.2×+4.4× | 13.5×+8.4× | 8.6×+4.6× | 7.5×+2.0× | 6.8×+2.6× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Guardant Health's profit margins?
- Guardant Health (GH) runs a 64.9% gross margin and a -41.4% operating margin, with a -40.1% net margin.
- Where do Guardant Health's ratios come from?
- Every ratio is computed from Guardant Health's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
